SEC Form 4 research
| Issuer | Harmony Biosciences Holdings, Inc. |
|---|---|
| Tickers | HRMY |
| Reporting owners | 32 |
| Officers and directors | 10 |
| Last public filing | 2026-09-18 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-18 | 2026-09-18 | Budur Kumar | S | 35,852 | $43.05 | Not reported |
| 2026-09-18 | 2026-09-17 | Budur Kumar | S | 800 | $43 | Not reported |
| 2026-09-18 | 2026-09-16 | Budur Kumar | S | 1,800 | $43.01 | Not reported |
| 2026-09-09 | 2026-09-08 | Budur Kumar | S | 22,954 | $43.1 | Not reported |
| 2026-09-09 | 2026-09-08 | Budur Kumar | S | 1,000 | $42.79 | Not reported |
| 2026-09-09 | 2026-09-08 | Budur Kumar | S | 4,500 | $42.25 | Not reported |
| 2026-09-09 | 2026-09-04 | Budur Kumar | S | 5,500 | $41.98 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.